|Bid||0.00 x 4000|
|Ask||0.00 x 2200|
|Day's Range||0.9853 - 1.0899|
|52 Week Range||0.9520 - 5.9900|
|Beta (3Y Monthly)||0.81|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 22, 2018 - Feb 26, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||9.00|
NEW YORK, NY / ACCESSWIRE / November 21, 2018 / It was a day of gains for biotech stocks Auris Medical Holding and Bioblast Pharma after the companies announced positive developments. Bioblast announced it has executed a definitive agreement to acquire Enlivex Therapeutics while Auris Medical announced the results of a Pre-IND meeting with the FDA. Auris Medical Holding AG shares were up nearly 36% on Tuesday on roughly 13.7 million shares traded.
Heading into the holiday week, a number of healthcare names are taking hold of a bull market in healthcare stocks. HealthVue currently has an ecosystem of over 100,000 active patients and have plans to rapidly increase that number both domestically and internationally.
Enlivex is developing a novel immunotherapy with a unique mode of action targeting clinical indications defined as “life-threatening, unmet medical need,” such as preventing or treating complications associated with bone-marrow transplantations, sepsis – which is the third-leading cause of mortality in the U.S. after cardiovascular and cancer diseases, as well as effective treatment of solid tumors via immune checkpoint reprogramming, increasing the efficacy of CAR-T, TCR and other anti-cancer therapies. Phase IIa clinical trial for the prevention of GvHD in matched-donor population successfully completed. Initiation of Phase II clinical trial in sepsis expected in Q2-2019, and initiation of a Phase II clinical trial for treatment of steroid-refractory GvHD patients and a Phase II/III clinical trial for preventing GvHD in bone marrow transplantations are expected in Q4-2019.
Today, I will be analyzing Bioblast Pharma Ltd’s (NASDAQ:ORPN) recent ownership structure, an important but not-so-popular subject among individual investors. When it comes to ownership structure of a company, theRead More...
Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user ! athenahealth, Inc (NASDAQ: ATHN ) stock was trading ...
If you are looking to invest in Bioblast Pharma Ltd’s (NASDAQ:ORPN), or currently own the stock, then you need to understand its beta in order to understand how it canRead More...
I am going to take a deep dive into Bioblast Pharma Ltd’s (NASDAQ:ORPN) most recent ownership structure, not a frequent subject of discussion among individual investors. A company’s ownership structureRead More...
In case you missed it, here are some of Benzinga's top stories from Wednesday, Jan. 17, 2018. Blockchain ETFs’ Inaugural Trading Session Wayne Duggan breaks down the arrival of new ETFs - Reality Shares ...